SABATINI, Stefano
 Distribuzione geografica
Continente #
AS - Asia 6.275
NA - Nord America 5.758
EU - Europa 4.045
SA - Sud America 572
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 115
OC - Oceania 15
Totale 17.200
Nazione #
US - Stati Uniti d'America 5.621
CN - Cina 2.651
SG - Singapore 1.914
IT - Italia 955
IE - Irlanda 606
HK - Hong Kong 544
UA - Ucraina 499
RU - Federazione Russa 498
VN - Vietnam 493
BR - Brasile 435
SE - Svezia 375
DE - Germania 258
FI - Finlandia 192
FR - Francia 183
GB - Regno Unito 139
KR - Corea 124
IN - India 103
BD - Bangladesh 81
TR - Turchia 71
BE - Belgio 70
CA - Canada 69
PL - Polonia 57
JP - Giappone 49
AR - Argentina 46
IQ - Iraq 45
MX - Messico 44
ES - Italia 38
NL - Olanda 34
PK - Pakistan 30
ZA - Sudafrica 29
ID - Indonesia 28
CH - Svizzera 25
EC - Ecuador 23
AT - Austria 22
UZ - Uzbekistan 21
RO - Romania 20
SA - Arabia Saudita 20
CZ - Repubblica Ceca 18
CO - Colombia 17
EG - Egitto 17
MA - Marocco 17
PH - Filippine 17
CL - Cile 15
VE - Venezuela 13
AU - Australia 11
ET - Etiopia 11
JO - Giordania 11
PT - Portogallo 11
AE - Emirati Arabi Uniti 9
IL - Israele 9
CI - Costa d'Avorio 8
KE - Kenya 8
LT - Lituania 8
PA - Panama 8
PY - Paraguay 8
TN - Tunisia 8
IR - Iran 7
LB - Libano 7
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
KZ - Kazakistan 5
LV - Lettonia 5
PE - Perù 5
AO - Angola 4
GR - Grecia 4
LY - Libia 4
MY - Malesia 4
AZ - Azerbaigian 3
DK - Danimarca 3
HR - Croazia 3
JM - Giamaica 3
NP - Nepal 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
CY - Cipro 1
DM - Dominica 1
Totale 16.764
Città #
Guangzhou 2.080
Singapore 1.406
Chandler 774
Dublin 606
San Jose 566
Hong Kong 531
Perugia 484
Ashburn 342
San Mateo 293
Dong Ket 276
Jacksonville 272
Santa Clara 220
Boardman 201
Moscow 151
Beijing 142
Medford 133
Princeton 133
Lauterbourg 128
Los Angeles 121
Seoul 121
Ann Arbor 101
Wilmington 100
Altamura 91
New York 91
Andover 79
The Dalles 78
Ho Chi Minh City 75
Munich 75
Brussels 70
Lawrence 70
São Paulo 55
Piscataway 54
Orem 51
Hanoi 50
Turku 50
Fremont 47
Redmond 46
Warsaw 46
Tokyo 42
Des Moines 39
Dallas 36
Rome 36
Saint Petersburg 36
Montreal 31
Brooklyn 30
Dearborn 30
Atlanta 29
Phoenix 28
Chicago 26
Helsinki 26
Council Bluffs 25
Norwalk 24
Buffalo 23
Izmir 23
Baghdad 22
Denver 22
Falls Church 21
Houston 21
West Jordan 20
Seattle 19
Spoleto 19
Stockholm 19
Ankara 18
Chennai 18
Woodbridge 18
London 17
Mexico City 17
Poplar 17
Johannesburg 16
Shanghai 16
Hefei 15
Rio de Janeiro 15
Charlotte 14
Redwood City 14
Secaucus 14
Vienna 14
Boston 13
Columbus 13
Mumbai 13
Porto Alegre 13
Amsterdam 12
Bologna 12
San Diego 12
Brasília 11
Addis Ababa 10
Barnet 10
Cairo 10
Da Nang 10
Den Haag 10
Dhaka 10
Manchester 10
Nuremberg 10
San Francisco 10
San Paolo di Civitate 10
Tashkent 10
Belo Horizonte 9
Frankfurt am Main 9
Lappeenranta 9
Querétaro 9
San Giustino 9
Totale 11.333
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.142
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 337
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 321
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 164
Alternate NF-κB-independent signaling reactivation of latent HIV-1 provirus 159
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 156
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 155
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 149
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 146
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 145
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 144
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 144
Efficient microwave assisted synthesis of metal-organic framework UiO-66: optimization and scale up 144
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 142
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 142
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 141
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 139
Derivati 2-fenilchinolonici come inibitori della pompa di efflusso NorA dello Staphylococcus aureus ciprofloxacin resistente 138
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 136
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 136
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 135
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 135
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 130
6-Desfluoroquinolones as promising HIV transcription inhibitors 129
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 129
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 128
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 125
S. aureus NorA efflux pump: the discovery of new potent inhibitors 125
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 124
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 124
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 123
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 121
A GRIND based pharmacophoric model for Factor Xa inhibitors 120
Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and selected herbal teas sourced in Ireland using LC-ESI-MS/MS 120
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 118
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 117
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 117
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 113
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 113
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 111
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 110
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 110
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 109
A new 6-aminoquinolone compound with anti-HCMV activity 109
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 109
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 109
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 108
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 108
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 107
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 107
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 106
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 106
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 105
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 105
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 104
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 103
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 103
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 103
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 102
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 102
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 101
Impact of conventional/non-conventional extraction methods on the untargeted phenolic profile of Moringa oleifera leaves 100
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 98
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 98
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 98
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 96
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 95
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 94
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 93
6-desfluorochinoloni (6-DFQ): sintesi assistita da microonde di 6-amino-7-(4-oxopiridinil) e 6-amino-7-(benzo-4-oxopiridinil) chinoloni 93
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 92
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 92
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 92
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 90
Nuovi Tiopiranopiridinil Chinoloni 90
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 89
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 89
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 87
Novel 1,4-Benzothiazine Derivatives as large conductance Ca2+-activated potassium channel activators 87
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 86
Novel 1,4-Benzothiazine Derivatives as Large Conductance Ca2+-Activated Potassium Channel Openers 86
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 86
Impact of conventional and non-conventional extraction methods on the untargeted phenolic profile of Moringa oleifera leaves 85
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 84
Biotinylated Tryptophan Catabolites for Target Fishing. 84
Design and Synthesis of Modified Quinolones as Antitumoral Acridones 83
Studi di molecular modeling per il disegno di inibitori COX-2 selettivi. 83
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 83
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains 82
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 81
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 80
Totale 13.623
Categoria #
all - tutte 68.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.216 0 195 17 71 97 12 50 364 54 33 162 161
2022/20232.236 141 340 36 212 193 236 16 130 799 13 80 40
2023/20243.109 73 145 52 20 21 26 2.303 21 133 49 121 145
2024/20252.494 40 193 105 223 272 145 258 136 440 136 353 193
2025/20265.250 341 329 222 667 732 515 873 254 567 448 205 97
2026/2027226 125 101 0 0 0 0 0 0 0 0 0 0
Totale 17.200